Eligibility Breast Neoplasms NCT02403869

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
patients who give their written informed consent.
Description

Informed Consent

Data type

boolean

Alias
UMLS CUI [1]
C0021430
patients with metastatic breast cancer who start treatment with second-line monochemotherapy.
Description

Secondary malignant neoplasm of female breast | Second line Chemotherapy

Data type

boolean

Alias
UMLS CUI [1]
C0346993
UMLS CUI [2,1]
C1710038
UMLS CUI [2,2]
C0392920
patients of both sexes, at least 18 years of age and of any race.
Description

Age | Racial group Any

Data type

boolean

Alias
UMLS CUI [1]
C0001779
UMLS CUI [2,1]
C0034510
UMLS CUI [2,2]
C1552551
patients with life expectancy longer than or equal to 12 weeks.
Description

Life Expectancy

Data type

boolean

Alias
UMLS CUI [1]
C0023671
patients with histological or cytological diagnosis of her-2/neu negative breast adenocarcinoma.
Description

Breast adenocarcinoma HER2/Neu Negative

Data type

boolean

Alias
UMLS CUI [1,1]
C0858252
UMLS CUI [1,2]
C2348908
patients with ability enough to understand the questionnaires.
Description

Comprehension Questionnaires

Data type

boolean

Alias
UMLS CUI [1,1]
C0162340
UMLS CUI [1,2]
C0034394
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
pregnant or lactating women.
Description

Pregnancy | Breast Feeding

Data type

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
patients who are participating or have participated in a clinical trial in the last two months.
Description

Study Subject Participation Status

Data type

boolean

Alias
UMLS CUI [1]
C2348568
patients who refuse to participate in the study.
Description

Refusal to Participate Clinical Trial

Data type

boolean

Alias
UMLS CUI [1,1]
C1136454
UMLS CUI [1,2]
C0008976

Similar models

Eligibility Breast Neoplasms NCT02403869

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Informed Consent
Item
patients who give their written informed consent.
boolean
C0021430 (UMLS CUI [1])
Secondary malignant neoplasm of female breast | Second line Chemotherapy
Item
patients with metastatic breast cancer who start treatment with second-line monochemotherapy.
boolean
C0346993 (UMLS CUI [1])
C1710038 (UMLS CUI [2,1])
C0392920 (UMLS CUI [2,2])
Age | Racial group Any
Item
patients of both sexes, at least 18 years of age and of any race.
boolean
C0001779 (UMLS CUI [1])
C0034510 (UMLS CUI [2,1])
C1552551 (UMLS CUI [2,2])
Life Expectancy
Item
patients with life expectancy longer than or equal to 12 weeks.
boolean
C0023671 (UMLS CUI [1])
Breast adenocarcinoma HER2/Neu Negative
Item
patients with histological or cytological diagnosis of her-2/neu negative breast adenocarcinoma.
boolean
C0858252 (UMLS CUI [1,1])
C2348908 (UMLS CUI [1,2])
Comprehension Questionnaires
Item
patients with ability enough to understand the questionnaires.
boolean
C0162340 (UMLS CUI [1,1])
C0034394 (UMLS CUI [1,2])
Item Group
C0680251 (UMLS CUI)
Pregnancy | Breast Feeding
Item
pregnant or lactating women.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Study Subject Participation Status
Item
patients who are participating or have participated in a clinical trial in the last two months.
boolean
C2348568 (UMLS CUI [1])
Refusal to Participate Clinical Trial
Item
patients who refuse to participate in the study.
boolean
C1136454 (UMLS CUI [1,1])
C0008976 (UMLS CUI [1,2])